Kai Cerrito
Wednesday, August 3, 2011
SMALL TYROSINE KINASE INHIBITORS OR MONOCLONAL ANTIBODIES TO EGFR.. LESS SIDE EFFECTS? WHY?
which type of drug, small tyrosine kinase inhibitors or monoclonal antibodies to EGFR, would you predict to have less adverse side effects and why?
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment